European Companies Search Engine
EU funding (€3,489,625): Cyber securitY tooLbox for COnnected MEdical Devices Hor1 Dec 2022 EU Research and Innovation programme "Horizon"
Text
Cyber securitY tooLbox for COnnected MEdical Devices
Accelerated digitalisation in health sector brings opportunities for cost-effective and efficient delivery of personalised care, through medical devices (including software) connected to IT networks and increasingly combined with novel technologies (AI, cloud computing, blockchain or 5G networks) and simultaneously Europe is witnessing an increase in the complexity and sophistication of attacks threatening such critical infrastructure. CYLCOMED addresses the overall ambitious goal of strengthening the cybersecurity of connected, in vitro diagnostic and software as medical devices (CMDs, IVDs, SaMD), maintaining their performance and safety for patients and preserving or enhancing the confidentiality, integrity and availability of private data they exchange or allow to be remotely accessed and focusing on humans operating the technology as the weakest link in the chain for security and privacy, with training and awareness measures tailored to healthcare staff needs. It does so by enabling adoption by all ecosystem stakeholders of technologically sovereign and trustworthy cybersecurity methodologies and toolboxes for connected medical devices and the environments in which they are managed and operate (platforms), complemented with fit-for-purpose guidance covering identifed risks and gaps. It will further deliver: (i) risk assessment framework with risk benefit analyses schemes and (ii) toolbox addressing cybersecurity risks and gaps in connected medical devices;(iii) assessment and extension of baseline standards, best practices and guidelines covering challenges for CMDs including SW, making them fit for purpose when used in conjunction with novel technologies; (iv) demonstrations and case studies in relevant on premise hospital scenarios (COVID-19 patients monitoring) and remote telemonitoring scenarios improving the life of paediatric patients. CYLCOMED has 9 partners from 7 EU Member States and 1 associate partner from Switzerland and a duration of 36 months.
Funded Companies:
| Company name | Funding amount |
| MARTEL GmbH | ? |
| Atos IT Solutions And Services Iberia SL | €0.00 |
| Atos Spain SA | €480,529 |
| CHARITE - UNIVERSITAETSMEDIZIN BERLIN | €600,629 |
| Fundacion para La Investigacion Biomedica Hospital Infantil Universitario Nino Jesus | €355,004 |
| Inov Instituto de Engenharia de Sistemas e Computadores Inovacao | €308,754 |
| Katholieke Universiteit Leuven | €295,629 |
| Mediaclinics Italia Srl | €375,629 |
| Ospedale Pediatrico Bambino Gesu | €313,129 |
| RGB Medical Devices SA | €358,754 |
| Xlab Razvoj Programske Opreme IN Svetovanje d.o.o. | €401,567 |
Source: https://cordis.europa.eu/project/id/101095542
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: MARTEL GmbH, Dübendorf, Switzerland.
The visualizations for "MARTEL GmbH - EU funding (€3,489,625): Cyber securitY tooLbox for COnnected MEdical Devices"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
